12:00 AM
Oct 15, 2012
 |  BC Week In Review  |  Company News  |  Management Tracks

Acorda management update

Acorda Therapeutics Inc. (NASDAQ:ACOR), Ardsley, N.Y.
Business: Neurology, Musculoskeletal, Autoimmune

Read the full 31 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >